Member Company


HelloBetter is the emergent category leader in the field of digital therapeutics (DTx) for mental health disorders and a global pioneer in the field of digital mental health research. Our mission is to empower people to manage and improve their mental health in a self-determined way, by allowing them to do so anywhere and at any time.

We offer scientifically validated (33 randomised controlled trials) DTx for a broad range of mental health disorders including Depression, Insomnia, Burnout, Anxiety and more. HelloBetter has expanded its portfolio to include other indications such as Chronic Pain Management, Vaginismus, and Alcohol Consumption.

Some publications from our randomised controlled trials and other research:

Note: for more research, please visit

Copyright © 2024 Digital Therapeutics Alliance™